mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.02 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |